US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arrowhead Pharmaceuticals

15.74

-0.4800-2.96%

Post-market: 15.52-0.2231-1.42%19:10 EDT

Volume:1.22M

Turnover:19.22M

Market Cap:2.17B

PE:-13.85

High:16.11

Open:15.62

Low:15.54

Close:16.22

Loading ...

Overview Company News Filings

Arrowhead reports Q2 EPS $2.75 vs. ($1.02) last year

Arrowhead Pharma Q2 EPS $2.75 Beats $(0.16) Estimate, Sales $542.71M Beat $29.91M Estimate

Arrowhead Pharmaceuticals Reports $542.7M Q2 Revenue, Swings to $370.4M Net Income; EPS Rises to $2.75

BRIEF-Arrowhead Pharmaceuticals Q2 EPS USD 2.75 Vs. IBES Estimate USD -0.2

Arrowhead Pharmaceuticals Reports Fiscal 2025 Second Quarter Results

THOMSON REUTERS

Arrowhead Pharmaceuticals Inc - Ken Myszkowski to Retire as CFO, Daniel Apel to Succeed

THOMSON REUTERS

Arrowhead Pharmaceuticals Names Daniel Apel Chief Financial Officer

MT Newswires Live

Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer

THOMSON REUTERS

Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer

BRIEF-Arrowhead Pharmaceuticals Says Ken Myszkowski To Retire As CFO

Arrowhead Pharmaceuticals Inc - Ken Myszkowski to Retire as CFO of Arrowhead Pharmaceuticals - SEC Filing

THOMSON REUTERS

Arrowhead Pharmaceuticals CEO Makes a Major Stock Sale!

This Type of Cholesterol Is a Risk Factor for Heart Disease. Emerging Drugs from Lilly and Amgen Could Treat It. -- Barrons.com

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Institutional investors may adopt severe steps after Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) latest 4.2% drop adds to a year losses

Simply Wall St.

Arrowhead Pharmaceuticals Stock Falls After Early-Stage Data From RNA-Based Therapeutic For Kidney Diseases

Arrowhead data supports blockbuster potential of ARO-C3, says H.C. Wainwright

Buy Rating for Arrowhead Pharmaceuticals Driven by Promising ARO-C3 Trial Results and Strategic Pipeline Advancements

Arrowhead Pharmaceuticals Says Study for Complement-Mediated Disease Therapy Shows C3 Reduction in Patients

MT Newswires Live

BRIEF-Arrowhead Pharmaceuticals Announces Topline Results From Part 2 Of Phase 1/2 Study Of Aro-C3 In Patients With IgA Nephropathy

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ARWR/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARWR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARWR\",,,,,undefined,":{"symbol":"ARWR","market":"US","secType":"STK","nameCN":"Arrowhead Pharmaceuticals","latestPrice":15.74,"timestamp":1749844800000,"preClose":16.22,"halted":0,"volume":1219137,"hourTrading":{"tag":"盘后","latestPrice":15.5169,"preClose":15.74,"latestTime":"19:10 EDT","volume":45673,"amount":718866.4012,"timestamp":1749856251747},"delay":0,"floatShares":119000000,"shares":138100435,"eps":-1.136657,"marketStatus":"Market Closed","change":-0.48,"latestTime":"06-13 16:00:00 EDT","open":15.62,"high":16.105,"low":15.54,"amount":19217001.731367,"amplitude":0.034834,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.136657,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750060800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":740203200000,"exchange":"NASDAQ","adjPreClose":16.22,"preHourTrading":{"tag":"盘前","latestPrice":15.65,"preClose":16.22,"latestTime":"09:29 EDT","volume":4650,"amount":74458.70625,"timestamp":1749821370033},"postHourTrading":{"tag":"盘后","latestPrice":15.5169,"preClose":15.74,"latestTime":"19:10 EDT","volume":45673,"amount":718866.4012,"timestamp":1749856251747},"volumeRatio":0.8686922854208706,"impliedVol":0.5721,"impliedVolPercentile":0.584},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARWR\",,,,,undefined,":{"symbol":"ARWR","floatShares":119000000,"roa":"-5.86%","roe":"-26.22%","lyrEps":-5.004783,"volumeRatio":0.8686922854208706,"shares":138100435,"dividePrice":0,"high":16.105,"amplitude":0.034834,"preClose":16.22,"low":15.54,"week52Low":9.57,"pbRate":"3.18","psRate":"3.99","week52High":30.41,"institutionHeld":0.7485,"latestPrice":15.74,"eps":-1.136657,"divideRate":0,"volume":1219137,"delay":0,"ttmEps":-1.136657,"open":15.62,"prevYearClose":18.8,"prevWeekClose":16.81,"prevMonthClose":16.07,"prevQuarterClose":12.74,"fiveDayClose":16.81,"twentyDayClose":15.34,"sixtyDayClose":15.47},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARWR\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2535781224","title":"Arrowhead reports Q2 EPS $2.75 vs. ($1.02) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2535781224","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535781224?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:21","pubTimestamp":1747081269,"startTime":"0","endTime":"0","summary":"“Arrowhead (ARWR) is in a strong and stable position as a business, and we have made meaningful progress towards our long-term goal of developing a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arrowhead-reports-q2-eps-2-75-vs-1-02-last-year?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arrowhead-reports-q2-eps-2-75-vs-1-02-last-year?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","ARWR","BK4585","BK4139"],"gpt_icon":0},{"id":"2535789688","title":"Arrowhead Pharma Q2 EPS $2.75 Beats $(0.16) Estimate, Sales $542.71M Beat $29.91M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535789688","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535789688?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:02","pubTimestamp":1747080170,"startTime":"0","endTime":"0","summary":"Arrowhead Pharma (NASDAQ:ARWR) reported quarterly earnings of $2.75 per share which beat the analyst consensus estimate of $(0.16) by 1818.75 percent. This is a 369.61 percent increase over losses of $(1.02) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45359060/arrowhead-pharma-q2-eps-2-75-beats-0-16-estimate-sales-542-71m-beat-29-91m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR"],"gpt_icon":0},{"id":"2535550789","title":"Arrowhead Pharmaceuticals Reports $542.7M Q2 Revenue, Swings to $370.4M Net Income; EPS Rises to $2.75","url":"https://stock-news.laohu8.com/highlight/detail?id=2535550789","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535550789?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:02","pubTimestamp":1747080120,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals Inc. announced its fiscal 2025 second-quarter financial results, revealing a significant increase in revenue, which reached $542.7 million compared to no revenue during the same period in 2024. The company's net income attributable to Arrowhead Pharmaceuticals, Inc. was $370.4 million, contrasting sharply with a net loss of $125.3 million in the previous year. This translated to a net income per diluted share of $2.75, compared to a loss of $1.02 per share in the prior year. The company recently finalized a licensing and collaboration agreement with Sarepta Therapeutics, receiving $825 million, consisting of $500 million in cash and $325 million as an equity investment. Arrowhead is set to receive an additional $250 million over five years, and is eligible for up to $10 billion in milestone payments, as well as royalties on commercial sales. Additionally, Arrowhead announced that the FDA has accepted the New Drug Application for investigational plozasiran, aim","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nNDL2X76KF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR","SRPT"],"gpt_icon":0},{"id":"2535789374","title":"BRIEF-Arrowhead Pharmaceuticals Q2 EPS USD 2.75 Vs. IBES Estimate USD -0.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2535789374","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535789374?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:01","pubTimestamp":1747080106,"startTime":"0","endTime":"0","summary":"May 12  - Arrowhead Pharmaceuticals Q2 operating income USD 381.202 million vs. IBES estimate USD -38.9 million.Q2 revenue USD 542.709 million vs. IBES estimate USD 29.9 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nPLX2736A4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR"],"gpt_icon":0},{"id":"2535178980","title":"Arrowhead Pharmaceuticals Reports Fiscal 2025 Second Quarter Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2535178980","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535178980?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:01","pubTimestamp":1747080061,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nTUABKT74R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","ARWR","BK4585","BK4139"],"gpt_icon":0},{"id":"2535789696","title":"Arrowhead Pharmaceuticals Inc - Ken Myszkowski to Retire as CFO, Daniel Apel to Succeed","url":"https://stock-news.laohu8.com/highlight/detail?id=2535789696","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535789696?lang=en_us&edition=fundamental","pubTime":"2025-05-13 04:01","pubTimestamp":1747080061,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nPLX2736A4:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARWR","BK4588","BK4139","BK4585"],"gpt_icon":0},{"id":"2527420616","title":"Arrowhead Pharmaceuticals Names Daniel Apel Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2527420616","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527420616?lang=en_us&edition=fundamental","pubTime":"2025-04-16 04:28","pubTimestamp":1744748901,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals  said late Tuesday it has appointed Daniel Apel as its chief financial officer, effective May 13, succeeding Ken Myszkowski, who will retire.Myszkowski will continue to offer his services as an employee adviser to ensure a smooth transition, the company said.Apel previously worked as global head of financial planning and analysis at Walgreens Boots Alliance , Arrowhead said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["WBA.AU","BK4139","ARWR","BK4588","BK4128","BK4585","LU0321505439.SGD","WBA","LU0321505868.SGD"],"gpt_icon":0},{"id":"2527197422","title":"Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2527197422","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527197422?lang=en_us&edition=fundamental","pubTime":"2025-04-16 04:00","pubTimestamp":1744747200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nTUA2BGD6F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARWR","BK4139","BK4585","BK4588"],"gpt_icon":0},{"id":"2527224724","title":"Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2527224724","media":"Business Wire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527224724?lang=en_us&edition=fundamental","pubTime":"2025-04-16 04:00","pubTimestamp":1744747200,"startTime":"0","endTime":"0","summary":"PASADENA, Calif., April 15, 2025----Arrowhead Pharmaceuticals, Inc.  today announced that, effective May 13, 2025, Arrowhead’s Chief Financial Officer, Ken Myszkowski, will retire after 16 years of service to the company and will be succeeded by Daniel Apel, who has been appointed as the company’s new Chief Financial Officer. Mr. Myszkowski will continue to serve as an employee adviser to assist and facilitate an effective transition.\"Ken has been a valuable member of the Arrowhead team, and he retires at a time of great financial strength for the company. The finance organization that Ken built over the years is very capable and provides strong support to our ambitious development and commercialization plans. I want to thank him for all his important contributions to Arrowhead,\" said Christopher Anzalone, Ph.D., President and CEO at Arrowhead. \"I am also excited for Dan Apel to join Arrowhead as we make the transition from development stage to commercial stage, with the planned launch","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arrowhead-pharmaceuticals-appoints-daniel-apel-200000334.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BIO","BK4121","BK4585","LU1169590202.USD","LU1169589451.USD","BK4139","BK4588","ARWR"],"gpt_icon":0},{"id":"2527042268","title":"BRIEF-Arrowhead Pharmaceuticals Says Ken Myszkowski To Retire As CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2527042268","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527042268?lang=en_us&edition=fundamental","pubTime":"2025-04-16 03:51","pubTimestamp":1744746707,"startTime":"0","endTime":"0","summary":"BRIEF-Arrowhead Pharmaceuticals Says Ken Myszkowski To Retire As CFOApril 15  - Arrowhead Pharmaceuticals Inc ARWR.O:ARROWHEAD PHARMACEUTICALS INC - KEN MYSZKOWSKI TO RETIRE AS CFO OF ARROWHEAD PHARMACEUTICALS - SEC FILINGARROWHEAD PHARMACEUTICALS INC - DANIEL APEL APPOINTED AS CFO OF ARROWHEAD PHARMACEUTICALS - SEC FILINGSource text: [ID:n0001628280-25-017844]Further company coverage: ARWR.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QT15A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2527742257","title":"Arrowhead Pharmaceuticals Inc - Ken Myszkowski to Retire as CFO of Arrowhead Pharmaceuticals - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2527742257","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527742257?lang=en_us&edition=fundamental","pubTime":"2025-04-16 03:50","pubTimestamp":1744746651,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QT15A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARWR","BK4588","BK4139","BK4585"],"gpt_icon":0},{"id":"2526620022","title":"Arrowhead Pharmaceuticals CEO Makes a Major Stock Sale!","url":"https://stock-news.laohu8.com/highlight/detail?id=2526620022","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526620022?lang=en_us&edition=fundamental","pubTime":"2025-04-12 10:01","pubTimestamp":1744423272,"startTime":"0","endTime":"0","summary":"New insider activity at Arrowhead Pharmaceuticals ( ($ARWR) ) has taken place on April 12, 2025. CEO Christopher Richard Anzalone has recently sold...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/arrowhead-pharmaceuticals-ceo-makes-a-major-stock-sale?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/arrowhead-pharmaceuticals-ceo-makes-a-major-stock-sale?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4588","ARWR","BK4585"],"gpt_icon":0},{"id":"2525057546","title":"This Type of Cholesterol Is a Risk Factor for Heart Disease. Emerging Drugs from Lilly and Amgen Could Treat It. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2525057546","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525057546?lang=en_us&edition=fundamental","pubTime":"2025-04-07 13:00","pubTimestamp":1744002000,"startTime":"0","endTime":"0","summary":"About a quarter of people risk heart attacks and strokes because they inherited a kind of cholesterol that statin drugs can't treat.However, Eli Lilly reported late last month that just one shot of an experimental drug eliminated most of this type of bad cholesterol, known as lipoprotein, for six months.Lilly is now enrolling patients for a Phase 3 trial of its drug, lepodisiran. Amgen has already recruited its Phase 3 study of olpasiran, a rival treatment for lipoprotein that is as powerful, if not quite as long-acting. Ahead of both is Novartis, whose Phase 3 trial of a monthly injection called pelacarsen could report results this year.These drugmakers are targeting a troublesome cholesterol variant that is a risk factor for cardiovascular disease distinct from the kind of cholesterol that is treated with statins. Since one to two billion people worldwide are born with high levels of lipoprotein, successful drugs should have a big market.Now, the companies have to show that lowering ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LU1093756168.USD","LU0106261372.USD","LU1280957306.USD","SG9999015952.SGD","LU2237443549.SGD","LU0203202063.USD","LU2237443622.USD","LU1868837300.USD","LU2491050071.SGD","SLN","LU0882574139.USD","LU0109391861.USD","LLY","IE0002141913.USD","IE00B1BXHZ80.USD","LU2491049909.HKD","LU2361044865.SGD","LU0417517546.SGD","BK4534","LU0471298694.HKD","LU1988902786.USD","LU0672654240.SGD","LU0471298777.SGD","LU0203201768.USD","IE00BFTCPJ56.SGD","LU0354030511.USD","LU2242652126.USD","BK4581","IE00BJLML261.HKD","LU2461242641.AUD","SG9999014906.USD","BK4007","SGXZ99366536.SGD","LU1061106388.HKD","LU1868836914.USD","IE00B2B36J28.USD","ARWR","LU2237443978.SGD","SG9999018865.SGD","AMGN","LU1814569148.SGD","SG9999015978.USD","LU0385154629.USD","LU1868836591.USD","LU0320765059.SGD","LU2265009873.SGD","LU1069344957.HKD","IE00BK4W5M84.HKD"],"gpt_icon":1},{"id":"2525307197","title":"Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2525307197","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525307197?lang=en_us&edition=fundamental","pubTime":"2025-04-05 04:30","pubTimestamp":1743798600,"startTime":"0","endTime":"0","summary":"PASADENA, Calif., April 04, 2025----Arrowhead Pharmaceuticals, Inc.  today announced that as an inducement to entering into employment with the Company, on April 3, 2025, the Company’s Board of Directors approved \"inducement\" grants to 21 new employees under Rule 5635 of the NASDAQ Listing Rules. The grants entitle employees, in aggregate, to receive up to 34,190 restricted stock units. The grants are outside the Company’s stockholder-approved equity incentive plans and vest annually over four years.Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Arrowhead’","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arrowhead-pharmaceuticals-reports-inducement-grants-203000518.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585",".IXIC","BK4112","IE00B64PRP62.GBP","NDAQ","ARWR","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2210150020.SGD","LU2210149790.SGD","LU2095319765.USD","BK4139","BK4588","IE00B3QW5Z07.USD"],"gpt_icon":1},{"id":"2518278188","title":"Institutional investors may adopt severe steps after Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) latest 4.2% drop adds to a year losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2518278188","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518278188?lang=en_us&edition=fundamental","pubTime":"2025-03-11 02:04","pubTimestamp":1741629841,"startTime":"0","endTime":"0","summary":"Key Insights Significantly high institutional ownership implies Arrowhead Pharmaceuticals' stock price is sensitive to...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-arwr/arrowhead-pharmaceuticals/news/institutional-investors-may-adopt-severe-steps-after-arrowhe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NDAQ","ARWR",".IXIC"],"gpt_icon":0},{"id":"2518206234","title":"Arrowhead Pharmaceuticals Stock Falls After Early-Stage Data From RNA-Based Therapeutic For Kidney Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2518206234","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518206234?lang=en_us&edition=fundamental","pubTime":"2025-03-11 02:02","pubTimestamp":1741629721,"startTime":"0","endTime":"0","summary":"On Monday, Arrowhead Pharmaceuticals, Inc. released topline results from Part 2 of a Phase 1/2 study of ARO-C3, the company’s investigational RNA interference  therapeutic designed to reduce liver production of complement component 3  as a potential therapy for various complement-mediated diseases.ARO-C3 is designed to reduce hepatocyte production of complement C3 as a potential treatment for various complement-mediated renal diseases.The dysregulated activity of the complement system can contribute to tissue injury and the progression of the disease. By silencing C3, investigational ARO-C3 has the potential to treat complement-mediated renal diseases by modulating the activation of the complement cascade.Also Read: Veren Soars On Whitecap Merger Deal: Details. The company plans to present additional results at a medical meeting in 2025.Pharmacodynamic effects: Maximum mean reduction in C3 of 89% and mean sustained reduction of greater than 87% from baseline through week 24.Maximum mea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arrowhead-pharmaceuticals-stock-falls-early-180201122.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SSI","BK4505","BK4588","BK4585","ARWR","BK4139","RNA"],"gpt_icon":0},{"id":"2518277683","title":"Arrowhead data supports blockbuster potential of ARO-C3, says H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2518277683","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518277683?lang=en_us&edition=fundamental","pubTime":"2025-03-11 00:20","pubTimestamp":1741623618,"startTime":"0","endTime":"0","summary":"H.C. Wainwright reiterates a Buy rating and $80 price target on shares of Arrowhead (ARWR) Pharmaceuticals after the company announced top-line dat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arrowhead-data-supports-blockbuster-potential-of-aro-c3-says-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arrowhead-data-supports-blockbuster-potential-of-aro-c3-says-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","ARWR","BK4588","BK4139"],"gpt_icon":0},{"id":"2518277662","title":"Buy Rating for Arrowhead Pharmaceuticals Driven by Promising ARO-C3 Trial Results and Strategic Pipeline Advancements","url":"https://stock-news.laohu8.com/highlight/detail?id=2518277662","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518277662?lang=en_us&edition=fundamental","pubTime":"2025-03-11 00:15","pubTimestamp":1741623318,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals (ARWR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Patrick Tr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-arrowhead-pharmaceuticals-driven-by-promising-aro-c3-trial-results-and-strategic-pipeline-advancements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-arrowhead-pharmaceuticals-driven-by-promising-aro-c3-trial-results-and-strategic-pipeline-advancements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARWR"],"gpt_icon":0},{"id":"2518216712","title":"Arrowhead Pharmaceuticals Says Study for Complement-Mediated Disease Therapy Shows C3 Reduction in Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2518216712","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518216712?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:12","pubTimestamp":1741612364,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals  said Monday that topline results of the clinical study of its investigational RNA interference therapeutic ARO-C3 showed an 89% mean reduction in complement component 3, supporting it as a potential therapy for various complement-mediated diseases.The second part of the phase 1/2 clinical study also showed reductions of 85% in AH50 and 100% in Wieslab AP, which are both markers of alternative pathway complement activity, in patients with IgA nephropathy, the company said.Arrowhead also reported that the therapy was generally well tolerated by the patients, with no serious or severe treatment adverse events.The study was designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of adult healthy volunteers and adult patients with complement-mediated renal disease.The company said it plans to present additional results at an upcoming medical meeting later this year.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","ARWR","BK4139","BK4585"],"gpt_icon":0},{"id":"2518240622","title":"BRIEF-Arrowhead Pharmaceuticals Announces Topline Results From Part 2 Of Phase 1/2 Study Of Aro-C3 In Patients With IgA Nephropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2518240622","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518240622?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:43","pubTimestamp":1741606996,"startTime":"0","endTime":"0","summary":"BRIEF-Arrowhead Pharmaceuticals Announces Topline Results From Part 2 Of Phase 1/2 Study Of Aro-C3 In Patients With IgA NephropathyMarch 10 (Reuters) - Arrowhead Pharmaceuticals Inc ARWR.O:ARROWHEAD P","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT0MA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","ARWR","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":99,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARWR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-12","symbol":"ARWR","fiscalQuarterEnding":"2025/03","expectedEps":-0.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":2.75},{"market":"US","date":"2025-02-10","symbol":"ARWR","fiscalQuarterEnding":"2024/12","expectedEps":-0.42,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739163600000,"reportTimeType":"post","actualEps":-1.39},{"market":"US","date":"2024-11-26","symbol":"ARWR","fiscalQuarterEnding":"2024/09","expectedEps":-0.63,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1732597200000,"reportTimeType":"post","actualEps":-1.38},{"market":"US","date":"2024-08-08","symbol":"ARWR","fiscalQuarterEnding":"2024/06","expectedEps":-0.58,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"post","actualEps":-1.38},{"market":"US","date":"2024-05-09","symbol":"ARWR","fiscalQuarterEnding":"2024/03","expectedEps":-0.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-1.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARWR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARWR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1333,"buy":0.5333,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5333,"analysts":15,"updateTime":1717646400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ARWR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ARWR","date":"2025-06-13","current":-15.558829,"percent":0.68878,"low":-296.588514,"twenty":-62.792449,"median":-23.478536,"eighty":-6.601655,"high":547.43255,"avg":-26.746963,"sd":100.105026,"marketCap":2239989055},"quantilePoints":[{"date":"2020-06-19","current":392.182515,"twenty":-18.275409,"median":-3.992874,"eighty":60.10843,"marketCap":3738132354},{"date":"2020-06-26","current":462.012999,"twenty":-18.275409,"median":-3.957597,"eighty":60.495173,"marketCap":4403729565},{"date":"2020-07-02","current":471.943021,"twenty":-18.275409,"median":-3.92846,"eighty":61.039647,"marketCap":4498378710},{"date":"2020-07-10","current":475.253029,"twenty":-18.275409,"median":-3.891958,"eighty":61.895529,"marketCap":4529928425},{"date":"2020-07-17","current":523.408301,"twenty":-18.275409,"median":-3.871005,"eighty":62.625798,"marketCap":4988925891},{"date":"2020-07-24","current":493.404684,"twenty":-18.275409,"median":-3.843641,"eighty":64.1913,"marketCap":4702942991},{"date":"2020-07-31","current":459.87751,"twenty":-18.275409,"median":-3.801907,"eighty":65.132645,"marketCap":4383374911},{"date":"2020-08-07","current":-168.551432,"twenty":-18.529695,"median":-3.789176,"eighty":65.318147,"marketCap":4115199234},{"date":"2020-08-14","current":-176.00909,"twenty":-18.968112,"median":-3.789176,"eighty":65.318147,"marketCap":4297278644},{"date":"2020-08-21","current":-178.020143,"twenty":-19.299259,"median":-3.789176,"eighty":65.318147,"marketCap":4346378709},{"date":"2020-08-28","current":-175.841502,"twenty":-19.749926,"median":-3.789176,"eighty":65.318147,"marketCap":4293186971},{"date":"2020-09-04","current":-150.99661,"twenty":-20.156605,"median":-3.789176,"eighty":65.318147,"marketCap":3686596580},{"date":"2020-09-11","current":-139.139773,"twenty":-20.285462,"median":-3.789176,"eighty":65.318147,"marketCap":3397110777},{"date":"2020-09-18","current":-180.575857,"twenty":-20.45098,"median":-3.789176,"eighty":65.318147,"marketCap":4408776709},{"date":"2020-09-25","current":-188.180154,"twenty":-20.855341,"median":-3.789176,"eighty":65.318147,"marketCap":4594436331},{"date":"2020-10-02","current":-183.592438,"twenty":-21.000912,"median":-3.789176,"eighty":65.318147,"marketCap":4482426807},{"date":"2020-10-09","current":-192.935458,"twenty":-21.181622,"median":-3.789176,"eighty":65.318147,"marketCap":4710537528},{"date":"2020-10-16","current":-206.887142,"twenty":-21.519563,"median":-3.789176,"eighty":65.318147,"marketCap":5051169232},{"date":"2020-10-23","current":-246.689245,"twenty":-21.724568,"median":-3.789176,"eighty":65.318147,"marketCap":6022941360},{"date":"2020-10-30","current":-240.069527,"twenty":-21.896478,"median":-3.789176,"eighty":65.318147,"marketCap":5861320311},{"date":"2020-11-06","current":-278.405237,"twenty":-22.1947,"median":-3.789176,"eighty":65.318147,"marketCap":6797290309},{"date":"2020-11-13","current":-287.1617,"twenty":-22.423055,"median":-3.789176,"eighty":65.318147,"marketCap":7011080177},{"date":"2020-11-20","current":-288.25102,"twenty":-22.812061,"median":-3.789176,"eighty":65.318147,"marketCap":7037676046},{"date":"2020-11-27","current":-76.551382,"twenty":-23.016886,"median":-3.789176,"eighty":65.318147,"marketCap":6472649005},{"date":"2020-12-04","current":-79.346559,"twenty":-23.27504,"median":-3.789176,"eighty":65.318147,"marketCap":6708989578},{"date":"2020-12-11","current":-90.004689,"twenty":-23.443255,"median":-3.789176,"eighty":65.318147,"marketCap":7610166460},{"date":"2020-12-18","current":-97.417984,"twenty":-23.662829,"median":-3.789176,"eighty":65.318147,"marketCap":8236982763},{"date":"2020-12-24","current":-102.315619,"twenty":-23.828206,"median":-3.789176,"eighty":65.318147,"marketCap":8651092550},{"date":"2020-12-31","current":-93.249524,"twenty":-23.877135,"median":-3.789176,"eighty":65.318147,"marketCap":7884527038},{"date":"2021-01-08","current":-97.077701,"twenty":-23.97186,"median":-3.789176,"eighty":65.318147,"marketCap":8208210867},{"date":"2021-01-15","current":-98.122854,"twenty":-24.454235,"median":-3.789176,"eighty":65.318147,"marketCap":8296581690},{"date":"2021-01-22","current":-99.739195,"twenty":-24.744147,"median":-3.789176,"eighty":65.318147,"marketCap":8433248195},{"date":"2021-01-29","current":-94.726725,"twenty":-24.828261,"median":-3.789176,"eighty":65.318147,"marketCap":8009428769},{"date":"2021-02-05","current":-91.510733,"twenty":-25.440997,"median":-3.789176,"eighty":65.318147,"marketCap":9390099332},{"date":"2021-02-12","current":-89.21462,"twenty":-26.042831,"median":-3.805477,"eighty":65.318147,"marketCap":9154490562},{"date":"2021-02-19","current":-90.53969,"twenty":-26.322299,"median":-3.843641,"eighty":65.318147,"marketCap":9290458619},{"date":"2021-02-26","current":-80.576379,"twenty":-26.916244,"median":-3.873833,"eighty":65.318147,"marketCap":8268103380},{"date":"2021-03-05","current":-69.79375,"twenty":-28.366158,"median":-3.907377,"eighty":65.320437,"marketCap":7161676290},{"date":"2021-03-12","current":-73.576774,"twenty":-29.531319,"median":-3.935488,"eighty":65.320437,"marketCap":7549859903},{"date":"2021-03-19","current":-68.175344,"twenty":-30.12048,"median":-3.970626,"eighty":65.320437,"marketCap":6995608434},{"date":"2021-03-26","current":-63.674153,"twenty":-30.547075,"median":-3.999327,"eighty":65.318147,"marketCap":6533732209},{"date":"2021-04-01","current":-67.841548,"twenty":-30.954671,"median":-4.016306,"eighty":65.318147,"marketCap":6961356938},{"date":"2021-04-09","current":-62.86495,"twenty":-31.342858,"median":-4.012792,"eighty":65.320437,"marketCap":6450698281},{"date":"2021-04-16","current":-68.42822,"twenty":-31.889554,"median":-4.012792,"eighty":65.320437,"marketCap":7021556536},{"date":"2021-04-23","current":-72.413545,"twenty":-32.415644,"median":-4.012792,"eighty":65.320437,"marketCap":7430498631},{"date":"2021-04-30","current":-73.597004,"twenty":-32.808234,"median":-4.012792,"eighty":65.320437,"marketCap":7551935751},{"date":"2021-05-07","current":-63.043178,"twenty":-45.932572,"median":-4.012792,"eighty":65.320437,"marketCap":6909154068},{"date":"2021-05-14","current":-69.168946,"twenty":-56.438632,"median":-4.033875,"eighty":65.320437,"marketCap":7580501519},{"date":"2021-05-21","current":-70.498571,"twenty":-57.863948,"median":-4.083069,"eighty":65.320437,"marketCap":7726220345},{"date":"2021-05-28","current":-68.950508,"twenty":-58.296058,"median":-4.111179,"eighty":65.320437,"marketCap":7556561997},{"date":"2021-06-04","current":-72.312558,"twenty":-58.476641,"median":-4.111179,"eighty":65.320437,"marketCap":7925022458},{"date":"2021-06-11","current":-84.250683,"twenty":-59.153827,"median":-4.111179,"eighty":65.320437,"marketCap":9233369349},{"date":"2021-06-18","current":-81.335007,"twenty":-59.54079,"median":-4.132262,"eighty":65.320437,"marketCap":8913828780},{"date":"2021-06-25","current":-85.779751,"twenty":-60.082539,"median":-4.188484,"eighty":65.320437,"marketCap":9400946000},{"date":"2021-07-02","current":-59.956551,"twenty":-60.959657,"median":-4.346124,"eighty":65.320437,"marketCap":6570878221},{"date":"2021-07-09","current":-63.764974,"twenty":-61.333721,"median":-4.547082,"eighty":65.320437,"marketCap":6988258574},{"date":"2021-07-16","current":-60.24147,"twenty":-61.430462,"median":-4.684632,"eighty":65.320437,"marketCap":6602103684},{"date":"2021-07-23","current":-64.933144,"twenty":-61.694887,"median":-4.836997,"eighty":65.320437,"marketCap":7116282972},{"date":"2021-07-30","current":-65.806897,"twenty":-62.139895,"median":-5.073506,"eighty":65.320437,"marketCap":7212041058},{"date":"2021-08-06","current":-53.65037,"twenty":-62.324426,"median":-5.25661,"eighty":65.320437,"marketCap":6754957196},{"date":"2021-08-13","current":-50.11453,"twenty":-62.324426,"median":-5.302386,"eighty":65.320437,"marketCap":6309770173},{"date":"2021-08-20","current":-49.625972,"twenty":-62.324426,"median":-5.37105,"eighty":65.320437,"marketCap":6248257212},{"date":"2021-08-27","current":-54.710294,"twenty":-62.324426,"median":-5.386309,"eighty":65.320437,"marketCap":6888409043},{"date":"2021-09-03","current":-55.935832,"twenty":-62.324426,"median":-5.401568,"eighty":65.320437,"marketCap":7042712742},{"date":"2021-09-10","current":-52.987918,"twenty":-62.324426,"median":-5.401568,"eighty":65.320437,"marketCap":6671549791},{"date":"2021-09-17","current":-53.7663,"twenty":-62.324426,"median":-5.500749,"eighty":65.320437,"marketCap":6769553492},{"date":"2021-09-24","current":-54.130649,"twenty":-62.324426,"median":-5.561784,"eighty":65.320437,"marketCap":6815427564},{"date":"2021-10-01","current":-51.836907,"twenty":-62.324426,"median":-9.576545,"eighty":65.320437,"marketCap":6526629425},{"date":"2021-10-08","current":-49.957198,"twenty":-62.324426,"median":-10.599494,"eighty":65.320437,"marketCap":6289960914},{"date":"2021-10-15","current":-54.78482,"twenty":-62.324426,"median":-12.617221,"eighty":65.320437,"marketCap":6897792376},{"date":"2021-10-22","current":-54.677172,"twenty":-62.324426,"median":-13.619752,"eighty":65.320437,"marketCap":6884238673},{"date":"2021-10-29","current":-52.847147,"twenty":-62.324426,"median":-14.182147,"eighty":65.320437,"marketCap":6653825717},{"date":"2021-11-05","current":-66.849736,"twenty":-62.691778,"median":-14.893608,"eighty":65.320437,"marketCap":8416849736},{"date":"2021-11-12","current":-61.227171,"twenty":-62.849328,"median":-15.49945,"eighty":65.320437,"marketCap":7708929388},{"date":"2021-11-19","current":-58.883745,"twenty":-62.849328,"median":-15.600362,"eighty":65.320437,"marketCap":7413875694},{"date":"2021-11-26","current":-53.447273,"twenty":-62.849328,"median":-15.768963,"eighty":65.320437,"marketCap":7527941490},{"date":"2021-12-03","current":-50.092904,"twenty":-62.849328,"median":-16.040498,"eighty":65.320437,"marketCap":7055485290},{"date":"2021-12-10","current":-52.000145,"twenty":-62.849328,"median":-16.358374,"eighty":65.320437,"marketCap":7324116359},{"date":"2021-12-17","current":-51.695877,"twenty":-62.849328,"median":-16.725153,"eighty":65.320437,"marketCap":7281260819},{"date":"2021-12-23","current":-52.133726,"twenty":-62.849328,"median":-16.774057,"eighty":65.320437,"marketCap":7342930987},{"date":"2021-12-31","current":-49.202363,"twenty":-62.849328,"median":-17.043029,"eighty":65.320437,"marketCap":6930054440},{"date":"2022-01-07","current":-43.747802,"twenty":-62.849328,"median":-17.532069,"eighty":65.318147,"marketCap":6161790486},{"date":"2022-01-14","current":-42.901789,"twenty":-62.849328,"median":-17.703232,"eighty":65.318147,"marketCap":6042631179},{"date":"2022-01-21","current":-37.729233,"twenty":-62.849328,"median":-17.9233,"eighty":65.318147,"marketCap":5314086994},{"date":"2022-01-28","current":-37.50079,"twenty":-62.849328,"median":-18.094464,"eighty":65.318147,"marketCap":5281911207},{"date":"2022-02-04","current":-28.67194,"twenty":-62.849328,"median":-18.47347,"eighty":65.318147,"marketCap":5246620871},{"date":"2022-02-11","current":-29.190628,"twenty":-62.849328,"median":-18.89431,"eighty":65.318147,"marketCap":5341534615},{"date":"2022-02-18","current":-25.502177,"twenty":-62.849328,"median":-19.299259,"eighty":65.318147,"marketCap":4666592433},{"date":"2022-02-25","current":-25.352334,"twenty":-62.849328,"median":-19.511471,"eighty":65.318147,"marketCap":4639172906},{"date":"2022-03-04","current":-24.735671,"twenty":-62.849328,"median":-19.873469,"eighty":65.318147,"marketCap":4526331010},{"date":"2022-03-11","current":-24.078666,"twenty":-62.849328,"median":-20.265536,"eighty":65.318147,"marketCap":4406106934},{"date":"2022-03-18","current":-27.30606,"twenty":-62.849328,"median":-20.427007,"eighty":65.318147,"marketCap":4996681344},{"date":"2022-03-25","current":-25.421493,"twenty":-62.849328,"median":-20.792261,"eighty":65.318147,"marketCap":4651828072},{"date":"2022-04-01","current":-28.354963,"twenty":-62.849328,"median":-20.994442,"eighty":65.318147,"marketCap":5188618027},{"date":"2022-04-08","current":-27.807459,"twenty":-62.849328,"median":-21.14622,"eighty":65.318147,"marketCap":5088431297},{"date":"2022-04-14","current":-27.012137,"twenty":-62.849328,"median":-21.291767,"eighty":65.318147,"marketCap":4942896888},{"date":"2022-04-22","current":-24.585828,"twenty":-62.849328,"median":-21.677169,"eighty":65.318147,"marketCap":4498911484},{"date":"2022-04-29","current":-23.692531,"twenty":-62.849328,"median":-21.85137,"eighty":65.318147,"marketCap":4335448924},{"date":"2022-05-06","current":-21.277749,"twenty":-62.849328,"median":-22.070043,"eighty":65.318147,"marketCap":3893572714},{"date":"2022-05-13","current":-29.922841,"twenty":-62.849328,"median":-22.230837,"eighty":65.318147,"marketCap":3345493368},{"date":"2022-05-20","current":-34.24482,"twenty":-62.849328,"median":-22.60735,"eighty":65.318147,"marketCap":3828707802},{"date":"2022-05-27","current":-32.343906,"twenty":-62.849328,"median":-22.835097,"eighty":65.318147,"marketCap":3616178040},{"date":"2022-06-03","current":-32.968086,"twenty":-62.849328,"median":-23.022811,"eighty":65.318147,"marketCap":3685963932},{"date":"2022-06-10","current":-28.863626,"twenty":-62.849328,"median":-23.265009,"eighty":65.318147,"marketCap":3227068824},{"date":"2022-06-17","current":-27.539606,"twenty":-62.849328,"median":-23.436785,"eighty":65.318147,"marketCap":3079038144},{"date":"2022-06-24","current":-32.589795,"twenty":-62.849328,"median":-23.562992,"eighty":65.320437,"marketCap":3643669452},{"date":"2022-07-01","current":-34.008387,"twenty":-62.849328,"median":-23.735995,"eighty":65.320437,"marketCap":3802273752},{"date":"2022-07-08","current":-39.465239,"twenty":-62.849328,"median":-23.824971,"eighty":65.320437,"marketCap":4412371626},{"date":"2022-07-15","current":-40.477169,"twenty":-62.849328,"median":-23.891697,"eighty":65.320437,"marketCap":4525509360},{"date":"2022-07-22","current":-40.354224,"twenty":-62.849328,"median":-23.943598,"eighty":65.320437,"marketCap":4511763654},{"date":"2022-07-29","current":-40.221822,"twenty":-62.849328,"median":-24.254281,"eighty":65.320437,"marketCap":4496960586},{"date":"2022-08-05","current":-31.604916,"twenty":-62.849328,"median":-24.559153,"eighty":65.320437,"marketCap":4864818339},{"date":"2022-08-12","current":-32.519506,"twenty":-62.849328,"median":-24.631934,"eighty":65.320437,"marketCap":5005597460},{"date":"2022-08-19","current":-29.301251,"twenty":-62.849328,"median":-24.78754,"eighty":65.320437,"marketCap":4510224313},{"date":"2022-08-26","current":-27.547714,"twenty":-62.849328,"median":-24.830151,"eighty":65.320437,"marketCap":4240309457},{"date":"2022-09-02","current":-27.107611,"twenty":-62.849328,"median":-25.139096,"eighty":65.320437,"marketCap":4172566121},{"date":"2022-09-09","current":-26.523099,"twenty":-62.849328,"median":-25.306228,"eighty":65.320437,"marketCap":4082594502},{"date":"2022-09-16","current":-23.786207,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3661315630},{"date":"2022-09-23","current":-21.269366,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3273908425},{"date":"2022-09-30","current":-22.727208,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3498308227},{"date":"2022-10-07","current":-21.743852,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3346944210},{"date":"2022-10-14","current":-22.018917,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3389283795},{"date":"2022-10-21","current":-22.961013,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3534296874},{"date":"2022-10-28","current":-24.666413,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3796802302},{"date":"2022-11-04","current":-23.35298,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3594630783},{"date":"2022-11-11","current":-23.71744,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3650730733},{"date":"2022-11-18","current":-21.124957,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3251680143},{"date":"2022-11-25","current":-20.28601,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3122544408},{"date":"2022-12-02","current":-20.428904,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3596774147},{"date":"2022-12-09","current":-18.207193,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3205613033},{"date":"2022-12-16","current":-19.12839,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3367801787},{"date":"2022-12-23","current":-23.060036,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":4060019152},{"date":"2022-12-30","current":-24.420759,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":4299592084},{"date":"2023-01-06","current":-22.506114,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3962493888},{"date":"2023-01-13","current":-22.168943,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3903130684},{"date":"2023-01-20","current":-20.326549,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3578753174},{"date":"2023-01-27","current":-20.236235,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3562852316},{"date":"2023-02-03","current":-22.267052,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3920403974},{"date":"2023-02-10","current":-23.21593,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3587232598},{"date":"2023-02-17","current":-23.657537,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3655468001},{"date":"2023-02-24","current":-22.872457,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3534160618},{"date":"2023-03-03","current":-22.676187,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3503833773},{"date":"2023-03-10","current":-18.442364,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":2849640388},{"date":"2023-03-17","current":-17.033427,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":2631936960},{"date":"2023-03-24","current":-17.026417,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":2630853859},{"date":"2023-03-31","current":-17.804487,"twenty":-62.849328,"median":-25.329281,"eighty":65.318147,"marketCap":2751078140},{"date":"2023-04-06","current":-17.713362,"twenty":-62.849328,"median":-25.329281,"eighty":65.318147,"marketCap":2736997819},{"date":"2023-04-14","current":-21.379404,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3303459971},{"date":"2023-04-21","current":-20.972845,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3240640076},{"date":"2023-04-28","current":-24.505704,"twenty":-62.849328,"median":-25.352334,"eighty":65.320437,"marketCap":3786523298},{"date":"2023-05-05","current":-28.503078,"twenty":-62.849328,"median":-25.406021,"eighty":65.320437,"marketCap":4281361861},{"date":"2023-05-12","current":-28.524429,"twenty":-62.849328,"median":-25.564592,"eighty":65.322728,"marketCap":4284568873},{"date":"2023-05-19","current":-25.820017,"twenty":-62.849328,"median":-25.767729,"eighty":65.327309,"marketCap":3878347273},{"date":"2023-05-26","current":-23.891344,"twenty":-62.849498,"median":-25.820017,"eighty":65.341771,"marketCap":3588647132},{"date":"2023-06-02","current":-24.6742,"twenty":-62.849668,"median":-25.85766,"eighty":65.356234,"marketCap":3706237596},{"date":"2023-06-09","current":-25.407238,"twenty":-62.849668,"median":-25.915884,"eighty":65.356234,"marketCap":3816345029},{"date":"2023-06-16","current":-25.435706,"twenty":-62.849668,"median":-25.915884,"eighty":65.356234,"marketCap":3820621046},{"date":"2023-06-23","current":-25.300485,"twenty":-62.849839,"median":-25.72783,"eighty":65.370696,"marketCap":3800309966},{"date":"2023-06-30","current":-25.570926,"twenty":-62.850009,"median":-25.674346,"eighty":65.385159,"marketCap":3840932126},{"date":"2023-07-07","current":-24.581681,"twenty":-62.850179,"median":-25.548283,"eighty":65.399621,"marketCap":3692340541},{"date":"2023-07-14","current":-24.546097,"twenty":-62.853133,"median":-25.4286,"eighty":65.437987,"marketCap":3686995520},{"date":"2023-07-21","current":-24.780953,"twenty":-62.853133,"median":-25.333526,"eighty":65.437987,"marketCap":3722272659},{"date":"2023-07-28","current":-25.499758,"twenty":-62.853133,"median":-25.303356,"eighty":65.437987,"marketCap":3830242084},{"date":"2023-08-04","current":-23.001735,"twenty":-62.853133,"median":-25.189784,"eighty":65.437987,"marketCap":3455021606},{"date":"2023-08-11","current":-17.14665,"twenty":-62.853133,"median":-25.145063,"eighty":65.437987,"marketCap":3105378341},{"date":"2023-08-18","current":-17.176244,"twenty":-62.853133,"median":-25.111888,"eighty":65.437987,"marketCap":3110737987},{"date":"2023-08-25","current":-16.596205,"twenty":-62.853133,"median":-25.111888,"eighty":65.437987,"marketCap":3005688944},{"date":"2023-09-01","current":-16.359455,"twenty":-62.853133,"median":-25.111888,"eighty":65.437987,"marketCap":2962811783},{"date":"2023-09-08","current":-17.886495,"twenty":-62.853133,"median":-25.073568,"eighty":65.437987,"marketCap":3239369468},{"date":"2023-09-15","current":-18.075895,"twenty":-62.856087,"median":-25.01581,"eighty":65.476352,"marketCap":3273671196},{"date":"2023-09-22","current":-16.116786,"twenty":-62.856087,"median":-24.951758,"eighty":65.476352,"marketCap":2918862694},{"date":"2023-09-29","current":-15.939223,"twenty":-62.856087,"median":-24.830151,"eighty":65.476352,"marketCap":2886704823},{"date":"2023-10-06","current":-15.122434,"twenty":-62.859042,"median":-24.823525,"eighty":65.514718,"marketCap":2738778620},{"date":"2023-10-13","current":-15.317753,"twenty":-62.859042,"median":-24.823525,"eighty":65.514718,"marketCap":2774152277},{"date":"2023-10-20","current":-15.004059,"twenty":-62.861996,"median":-24.825913,"eighty":65.553083,"marketCap":2717340040},{"date":"2023-10-23","current":-15.057327,"twenty":-62.861996,"median":-24.825913,"eighty":65.553083,"marketCap":2726987401},{"date":"2023-11-03","current":-15.483478,"twenty":-62.913621,"median":-24.830151,"eighty":65.661983,"marketCap":2804166290},{"date":"2023-11-10","current":-15.826766,"twenty":-62.913621,"median":-24.825913,"eighty":65.661983,"marketCap":2866338172},{"date":"2023-11-17","current":-15.424291,"twenty":-62.913621,"median":-24.825913,"eighty":65.661983,"marketCap":2793447000},{"date":"2023-11-24","current":-17.235431,"twenty":-62.913621,"median":-24.825913,"eighty":65.661983,"marketCap":3121457277},{"date":"2023-12-01","current":-11.082764,"twenty":-62.913621,"median":-24.825913,"eighty":65.661983,"marketCap":2275014400},{"date":"2023-12-08","current":-12.837959,"twenty":-62.897398,"median":-24.823525,"eighty":65.638472,"marketCap":2635312111},{"date":"2023-12-15","current":-14.941857,"twenty":-62.897398,"median":-24.799067,"eighty":65.638472,"marketCap":3067189595},{"date":"2023-12-22","current":-15.051762,"twenty":-62.897398,"median":-24.799067,"eighty":65.638472,"marketCap":3089750359},{"date":"2023-12-29","current":-16.224082,"twenty":-62.913621,"median":-24.810593,"eighty":65.661983,"marketCap":3330398510},{"date":"2024-01-05","current":-20.727623,"twenty":-62.929845,"median":-24.815865,"eighty":65.685495,"marketCap":4254862911},{"date":"2024-01-12","current":-22.510451,"twenty":-62.929845,"median":-24.780146,"eighty":65.685495,"marketCap":4620832875},{"date":"2024-01-19","current":-19.905242,"twenty":-62.946069,"median":-24.739411,"eighty":65.709006,"marketCap":4086048483},{"date":"2024-01-26","current":-20.061314,"twenty":-62.929845,"median":-24.737541,"eighty":65.685495,"marketCap":4118086258},{"date":"2024-02-02","current":-19.419562,"twenty":-62.929845,"median":-24.715611,"eighty":65.685495,"marketCap":3986350531},{"date":"2024-02-09","current":-12.877492,"twenty":-62.929845,"median":-24.670306,"eighty":65.685495,"marketCap":3822219796},{"date":"2024-02-16","current":-12.343191,"twenty":-62.929845,"median":-24.583754,"eighty":65.685495,"marketCap":3663631746},{"date":"2024-02-23","current":-12.606167,"twenty":-62.929845,"median":-24.5259,"eighty":65.685495,"marketCap":3741686802},{"date":"2024-03-01","current":-13.39927,"twenty":-62.849839,"median":-24.403759,"eighty":65.661983,"marketCap":3977090939},{"date":"2024-03-08","current":-13.858435,"twenty":-62.78865,"median":-24.183136,"eighty":65.661983,"marketCap":4113377544},{"date":"2024-03-15","current":-11.445732,"twenty":-62.78865,"median":-24.078666,"eighty":65.661983,"marketCap":3397253381},{"date":"2024-03-22","current":-11.783844,"twenty":-62.78865,"median":-23.934586,"eighty":65.661983,"marketCap":3497609882},{"date":"2024-03-28","current":-11.980033,"twenty":-62.78865,"median":-23.867826,"eighty":65.661983,"marketCap":3555841431},{"date":"2024-04-05","current":-10.898908,"twenty":-62.771965,"median":-23.697907,"eighty":65.685495,"marketCap":3234948424},{"date":"2024-04-12","current":-10.719416,"twenty":-62.450545,"median":-23.597561,"eighty":65.685495,"marketCap":3181672751},{"date":"2024-04-19","current":-9.437928,"twenty":-62.450545,"median":-23.514443,"eighty":65.685495,"marketCap":2801309225},{"date":"2024-04-26","current":-9.129035,"twenty":-62.427752,"median":-23.37361,"eighty":65.661983,"marketCap":2709625509},{"date":"2024-05-03","current":-10.072411,"twenty":-62.427752,"median":-23.21593,"eighty":65.661983,"marketCap":2989632534},{"date":"2024-05-10","current":-6.482305,"twenty":-62.427752,"median":-23.186475,"eighty":65.370696,"marketCap":3068567760},{"date":"2024-05-17","current":-6.595323,"twenty":-62.427752,"median":-23.186475,"eighty":64.679241,"marketCap":3105005750},{"date":"2024-05-24","current":-6.508265,"twenty":-62.427752,"median":-23.186475,"eighty":63.492771,"marketCap":3064019674},{"date":"2024-05-31","current":-6.009659,"twenty":-62.427752,"median":-23.186475,"eighty":62.516156,"marketCap":2829281239},{"date":"2024-06-07","current":-6.513541,"twenty":-62.427752,"median":-23.186475,"eighty":61.77678,"marketCap":3066503678},{"date":"2024-06-14","current":-6.991043,"twenty":-62.450545,"median":-23.188804,"eighty":61.001953,"marketCap":3291306095},{"date":"2024-06-21","current":-6.27611,"twenty":-62.473339,"median":-23.191133,"eighty":60.436538,"marketCap":2954723471},{"date":"2024-06-28","current":-6.777354,"twenty":-62.570212,"median":-23.208812,"eighty":59.933947,"marketCap":3190703908},{"date":"2024-07-05","current":-6.61379,"twenty":-62.570212,"median":-23.208812,"eighty":58.878506,"marketCap":3113699766},{"date":"2024-07-12","current":-7.452716,"twenty":-62.570212,"median":-23.208812,"eighty":57.044321,"marketCap":3508656497},{"date":"2024-07-15","current":-7.415782,"twenty":-62.570212,"median":-23.208812,"eighty":56.809508,"marketCap":3491268465},{"date":"2024-08-02","current":-7.244303,"twenty":-62.781052,"median":-23.464332,"eighty":50.761782,"marketCap":3410538315},{"date":"2024-08-09","current":-5.966088,"twenty":-62.781052,"median":-23.464332,"eighty":47.94868,"marketCap":3213549832},{"date":"2024-08-16","current":-5.229847,"twenty":-62.781052,"median":-23.464332,"eighty":-5.237233,"marketCap":2816984108},{"date":"2024-08-23","current":-5.624509,"twenty":-62.781052,"median":-23.464332,"eighty":-5.400175,"marketCap":3029563227},{"date":"2024-08-30","current":-5.557578,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2993511797},{"date":"2024-09-06","current":-5.366017,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2890330120},{"date":"2024-09-13","current":-4.670166,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2515519569},{"date":"2024-09-20","current":-4.879037,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2628024892},{"date":"2024-09-27","current":-4.528226,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2439065675},{"date":"2024-10-04","current":-4.350513,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2343342914},{"date":"2024-10-11","current":-4.085097,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2200380349},{"date":"2024-10-18","current":-4.809798,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2590730310},{"date":"2024-10-25","current":-4.599773,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2477603410},{"date":"2024-10-31","current":-4.548998,"twenty":-62.781052,"median":-23.464332,"eighty":-5.611123,"marketCap":2450254050},{"date":"2024-11-08","current":-4.936736,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2659103710},{"date":"2024-11-15","current":-4.941352,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2661590016},{"date":"2024-11-22","current":-4.218959,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2272483208},{"date":"2024-11-29","current":-5.402946,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":3239028525},{"date":"2024-12-06","current":-4.628725,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2774888056},{"date":"2024-12-13","current":-4.595514,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2754978545},{"date":"2024-12-20","current":-4.04754,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2426471619},{"date":"2024-12-27","current":-4.053767,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2430204652},{"date":"2025-01-03","current":-4.078674,"twenty":-62.784851,"median":-23.466049,"eighty":-5.670207,"marketCap":2445136785},{"date":"2025-01-10","current":-4.099431,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2457580229},{"date":"2025-01-17","current":-3.947908,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2366743086},{"date":"2025-01-24","current":-4.468899,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2679073536},{"date":"2025-01-31","current":-4.199063,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2517308761},{"date":"2025-02-07","current":-4.27277,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2561495982},{"date":"2025-02-14","current":-3.766894,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2409734901},{"date":"2025-02-21","current":-4.131559,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2643016406},{"date":"2025-02-28","current":-3.733384,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":2388298222},{"date":"2025-03-07","current":-3.483047,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":2228153621},{"date":"2025-03-14","current":-2.970544,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1900298532},{"date":"2025-03-21","current":-2.978429,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1905342457},{"date":"2025-03-28","current":-2.720206,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1740153931},{"date":"2025-04-04","current":-2.377224,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1520743218},{"date":"2025-04-11","current":-2.189963,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":1400950013},{"date":"2025-04-17","current":-2.237271,"twenty":-62.78865,"median":-23.467766,"eighty":-5.708058,"marketCap":1431213559},{"date":"2025-04-25","current":-2.629533,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1682148800},{"date":"2025-05-02","current":-2.767514,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1770417478},{"date":"2025-05-09","current":-2.611792,"twenty":-62.792449,"median":-23.478536,"eighty":-5.739251,"marketCap":1670799970},{"date":"2025-05-16","current":-14.7147,"twenty":-62.792449,"median":-23.478536,"eighty":-5.974802,"marketCap":2118460672},{"date":"2025-05-23","current":-14.762662,"twenty":-62.792449,"median":-23.478536,"eighty":-6.230734,"marketCap":2125365694},{"date":"2025-05-30","current":-16.134371,"twenty":-62.792449,"median":-23.478536,"eighty":-6.469305,"marketCap":2322849316},{"date":"2025-06-06","current":-15.789046,"twenty":-62.792449,"median":-23.478536,"eighty":-6.537285,"marketCap":2273133160},{"date":"2025-06-13","current":-15.558829,"twenty":-62.792449,"median":-23.478536,"eighty":-6.601655,"marketCap":2239989055}],"updateTime":1749944768122}}}